이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

국립암연구소 "암문샷 바이오뱅크"

2026년 11월 11일 업데이트: National Cancer Institute (NCI)

Cancer Moonshot Biobank 연구 프로토콜

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

연구 개요

상세 설명

PRIMARY OBJECTIVE:

I. To support current and future investigations into drug resistance and sensitivity and other National Cancer Institute (NCI)-sponsored cancer research initiatives through the procurement and distribution of multiple longitudinal biospecimens and associated data from a diverse group of cancer patients who are undergoing standard of care treatment at NCI Community Oncology Research Program (NCORP) sites and other National Clinical Trials Network (NCTN) sites.

SECONDARY OBJECTIVES:

I. To provide a service of value to study participants and their medical providers through the performance of molecular profiling assays on tumor samples in a Clinical Laboratory Improvement Act (CLIA)-certified laboratory and reporting of results to physicians and patients that they may opt to use in clinical management, including analysis of data for acquired resistance mechanisms.

II. To enable the development of patient-derived models such as cell lines and xenografts for cancer researchers through the provision of biospecimens from up to 20% of study participants to the NCI's Patient Derived Models Repository (PDMR), a national resource available to investigators.

III. To develop and implement robust approaches in patient and provider engagement to improve understanding of biobanking and its relationship to cancer research and increase representation of minority and underserved study participants in cancer research.

IV. To develop increased capabilities in United States (U.S.) community hospitals and clinics for contribution to cancer research through biobanking activities.

V. To enable secondary research generated from the project through deposition of data in public repositories such as Cancer Research Data Commons (CRDC), The Cancer Imaging Archive (TCIA) and database of Genotypes and Phenotypes (dbGaP) and other potential NCI databases, including clinical, radiology and pathology data with an emphasis on treatment response and outcome data.

VI. To provide residual biospecimens and associated data from the project to the cancer research community.

OUTLINE:

Patients undergo collection of tissue samples during baseline and at time of disease progression and collection of blood samples throughout the study, including at time of disease progression. Patients with hematological malignancies also undergo collection of bone marrow and cerebral spinal fluid at the same time points. Archival blood and tissue, as well as bone marrow of patients with hematological malignancies, is also collected if available. Additionally, patients may undergo computed tomography (CT), positron emission tomography (PET)/CT and/or magnetic resonance imaging (MRI) throughout the study, and may undergo paracentesis on study. Patient medical records are reviewed, and data is collected for at least 5 years.

연구 유형

관찰

등록 (추정된)

1600

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Alabama
      • Daphne, Alabama, 미국, 36526
        • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis
      • Fairhope, Alabama, 미국, 36532
        • Thomas Hospital
      • Mobile, Alabama, 미국, 36607
        • Mobile Infirmary Medical Center
      • Saraland, Alabama, 미국, 36571
        • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland
    • Arizona
      • Kingman, Arizona, 미국, 86401
        • Kingman Regional Medical Center
    • Arkansas
      • Fort Smith, Arkansas, 미국, 72903
        • Mercy Hospital Fort Smith
    • California
      • Arroyo Grande, California, 미국, 93420
        • PCR Oncology
      • Bakersfield, California, 미국, 93301
        • AIS Cancer Center at San Joaquin Community Hospital
      • Loma Linda, California, 미국, 92357
        • Veterans Affairs Loma Linda Healthcare System
      • Salinas, California, 미국, 93901
        • Salinas Valley Memorial
    • Colorado
      • Brighton, Colorado, 미국, 80601
        • Intermountain Health Platte Valley Hospital
      • Denver, Colorado, 미국, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Golden, Colorado, 미국, 80401
        • Lutheran Hospital - Cancer Centers of Colorado
      • Grand Junction, Colorado, 미국, 81501
        • Saint Mary's Hospital and Regional Medical Center
      • Lafayette, Colorado, 미국, 80026
        • Good Samaritan Hospital - Cancer Centers of Colorado
    • Connecticut
      • Hartford, Connecticut, 미국, 06102
        • Hartford Hospital
    • Delaware
      • Dover, Delaware, 미국, 19901
        • Bayhealth Hospital Kent Campus
      • Milford, Delaware, 미국, 19963
        • Bayhealth Hospital Sussex Campus
    • Florida
      • Boca Raton, Florida, 미국, 33486
        • Boca Raton Regional Hospital
      • Deerfield Beach, Florida, 미국, 33064
        • Broward Health North
      • Fort Lauderdale, Florida, 미국, 33316
        • Broward Health Medical Center
      • Tampa, Florida, 미국, 33606
        • Tampa General Hospital
    • Georgia
      • Atlanta, Georgia, 미국, 30342
        • Northside Hospital
      • Savannah, Georgia, 미국, 31405
        • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
    • Illinois
      • Bloomington, Illinois, 미국, 61704
        • Illinois CancerCare-Bloomington
      • Chicago, Illinois, 미국, 60612
        • John H Stroger Jr Hospital of Cook County
      • Chicago, Illinois, 미국, 60625
        • Swedish Covenant Hospital
      • Danville, Illinois, 미국, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, 미국, 62526
        • Decatur Memorial Hospital
      • Decatur, Illinois, 미국, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Evanston, Illinois, 미국, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, 미국, 61401
        • Illinois CancerCare-Galesburg
      • Glenview, Illinois, 미국, 60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Highland Park, Illinois, 미국, 60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Mattoon, Illinois, 미국, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Mount Vernon, Illinois, 미국, 62864
        • SSM Health Good Samaritan
      • Pekin, Illinois, 미국, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, 미국, 61615
        • Illinois CancerCare-Peoria
      • Urbana, Illinois, 미국, 61801
        • Carle Cancer Center
      • Washington, Illinois, 미국, 61571
        • Illinois CancerCare - Washington
    • Iowa
      • Ames, Iowa, 미국, 50010
        • McFarland Clinic - Ames
      • Bettendorf, Iowa, 미국, 52722
        • University of Iowa Healthcare Cancer Services Quad Cities
      • Cedar Rapids, Iowa, 미국, 52403
        • Oncology Associates at Mercy Medical Center
      • Cedar Rapids, Iowa, 미국, 52402
        • Physicians' Clinic of Iowa PC
      • Des Moines, Iowa, 미국, 50309
        • Iowa Methodist Medical Center
      • Des Moines, Iowa, 미국, 50309
        • Blank Children's Hospital
      • Des Moines, Iowa, 미국, 50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Iowa City, Iowa, 미국, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
    • Louisiana
      • Baton Rouge, Louisiana, 미국, 70808
        • Our Lady of the Lake Physician Group
      • New Orleans, Louisiana, 미국, 70118
        • Children's Hospital New Orleans
      • New Orleans, Louisiana, 미국, 70112
        • University Medical Center New Orleans
      • Shreveport, Louisiana, 미국, 71103
        • LSU Health Sciences Center at Shreveport
    • Maine
      • Augusta, Maine, 미국, 04330
        • Harold Alfond Center for Cancer Care
      • Belfast, Maine, 미국, 04915
        • MaineHealth Waldo Hospital
      • Biddeford, Maine, 미국, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Brunswick, Maine, 미국, 04011
        • MaineHealth Cancer Care and IV Therapy - Brunswick
      • Brunswick, Maine, 미국, 04011
        • Mid Coast Hospital
      • Damariscotta, Maine, 미국, 04543
        • MaineHealth LincolnHealth Hospital
      • Farmington, Maine, 미국, 04938
        • MaineHealth Franklin Hospital
      • Lewiston, Maine, 미국, 04240
        • Saint Mary's Regional Medical Center
      • Norway, Maine, 미국, 04268
        • MaineHealth Stephens Hospital
      • Portland, Maine, 미국, 04102
        • Maine Medical Partners Surgical Care
      • Portland, Maine, 미국, 04102
        • MMP Surgical Care Casco Bay
      • Portland, Maine, 미국, 04102
        • MaineHealth Maine Medical Center - Portland
      • Rockport, Maine, 미국, 04856
        • Penobscot Bay Medical Center
      • Sanford, Maine, 미국, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • Scarborough, Maine, 미국, 04074
        • Maine Children's Cancer Program
      • Scarborough, Maine, 미국, 04074
        • MaineHealth Maine Medical Center- Scarborough
      • South Portland, Maine, 미국, 04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
      • South Portland, Maine, 미국, 04106
        • MaineHealth Urology - South Portland
    • Michigan
      • Ann Arbor, Michigan, 미국, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Brighton, Michigan, 미국, 48114
        • Trinity Health Medical Center - Brighton
      • Canton, Michigan, 미국, 48188
        • Trinity Health Medical Center - Canton
      • Chelsea, Michigan, 미국, 48118
        • Chelsea Hospital
      • Grand Rapids, Michigan, 미국, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Iron Mountain, Michigan, 미국, 49801
        • Dickinson County Healthcare System
      • Livonia, Michigan, 미국, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Pontiac, Michigan, 미국, 48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
    • Missouri
      • Ballwin, Missouri, 미국, 63011
        • Mercy Oncology and Hematology - Clayton-Clarkson
      • Joplin, Missouri, 미국, 64804
        • Freeman Health System
      • Joplin, Missouri, 미국, 64804
        • Mercy Hospital Joplin
      • Rolla, Missouri, 미국, 65401
        • Mercy Clinic-Rolla-Cancer and Hematology
      • Rolla, Missouri, 미국, 65401
        • Phelps Health Delbert Day Cancer Institute
      • Saint Joseph, Missouri, 미국, 64506
        • Heartland Regional Medical Center
      • Springfield, Missouri, 미국, 65807
        • CoxHealth South Hospital
      • Springfield, Missouri, 미국, 65804
        • Mercy Hospital Springfield
      • St Louis, Missouri, 미국, 63131
        • Missouri Baptist Medical Center
      • St Louis, Missouri, 미국, 63109
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, 미국, 63141
        • Mercy Hospital Saint Louis
      • St Louis, Missouri, 미국, 63128
        • Mercy Hospital South
      • Washington, Missouri, 미국, 63090
        • Mercy Hospital Washington
    • Montana
      • Billings, Montana, 미국, 59102
        • Saint Vincent Frontier Cancer Center
      • Butte, Montana, 미국, 59701
        • Saint James Community Hospital and Cancer Treatment Center
    • Nebraska
      • Grand Island, Nebraska, 미국, 68803
        • Nebraska Cancer Specialists/Oncology Hematology West PC
    • Nevada
      • Carson City, Nevada, 미국, 89703
        • Carson Tahoe Regional Medical Center
      • Las Vegas, Nevada, 미국, 89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas, Nevada, 미국, 89135
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, 미국, 89144
        • Comprehensive Cancer Centers of Nevada - Town Center
      • Las Vegas, Nevada, 미국, 89148
        • Comprehensive Cancer Centers of Nevada
      • Las Vegas, Nevada, 미국, 89169
        • Comprehensive Cancer Centers of Nevada - Central Valley
      • Las Vegas, Nevada, 미국, 89103
        • Hope Cancer Care of Nevada
      • Las Vegas, Nevada, 미국, 89183
        • OptumCare Cancer Care at Fort Apache
    • New Hampshire
      • Nashua, New Hampshire, 미국, 03060
        • Saint Joseph Hospital
    • New Jersey
      • Morristown, New Jersey, 미국, 07960
        • Morristown Medical Center
      • Newton, New Jersey, 미국, 07860
        • Newton Medical Center
      • Pompton, New Jersey, 미국, 07444
        • Chilton Medical Center
      • Summit, New Jersey, 미국, 07902
        • Overlook Hospital
    • New York
      • New York, New York, 미국, 10032
        • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
      • The Bronx, New York, 미국, 10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx, New York, 미국, 10467
        • Children's Hospital at Montefiore
      • The Bronx, New York, 미국, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, 미국, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Carolina
      • Charlotte, North Carolina, 미국, 28204
        • Novant Health Presbyterian Medical Center
      • Greenville, North Carolina, 미국, 27834
        • East Carolina University
      • Greenville, North Carolina, 미국, 27834
        • ECU Health Medical Center
      • Kernersville, North Carolina, 미국, 27284
        • Novant Health Cancer Institute - Kernersville
      • Kinston, North Carolina, 미국, 28501
        • ECU Health Oncology Kinston
      • Mount Airy, North Carolina, 미국, 27030
        • Novant Health Cancer Institute - Mount Airy
      • Pinehurst, North Carolina, 미국, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Thomasville, North Carolina, 미국, 27360
        • Novant Health Cancer Institute - Thomasville
      • Washington, North Carolina, 미국, 27889
        • Marion L Shepard Cancer Center - ECU Health Beaufort Hospital
      • Winston-Salem, North Carolina, 미국, 27103
        • Novant Health Forsyth Medical Center
    • Oklahoma
      • Oklahoma City, Oklahoma, 미국, 73120
        • Mercy Hospital Oklahoma City
    • Rhode Island
      • Providence, Rhode Island, 미국, 02908
        • Roger Williams Medical Center
    • South Carolina
      • Columbia, South Carolina, 미국, 29203
        • Prisma Health Richland Hospital
      • Columbia, South Carolina, 미국, 29220
        • Prisma Health Baptist Hospital
      • Gaffney, South Carolina, 미국, 29341
        • Gibbs Cancer Center-Gaffney
      • Greenville, South Carolina, 미국, 29605
        • Prisma Health Greenville Memorial Hospital
      • Greer, South Carolina, 미국, 29651
        • Gibbs Cancer Center-Pelham
      • Spartanburg, South Carolina, 미국, 29303
        • Spartanburg Medical Center
      • Union, South Carolina, 미국, 29379
        • SMC Center for Hematology Oncology Union
    • Texas
      • San Antonio, Texas, 미국, 78229
        • Audie L Murphy VA Hospital
    • Virginia
      • Lynchburg, Virginia, 미국, 24501
        • Centra Alan B Pearson Regional Cancer Center
      • Richmond, Virginia, 미국, 23235
        • VCU Massey Cancer Center at Stony Point
      • Richmond, Virginia, 미국, 23298
        • VCU Massey Comprehensive Cancer Center
    • Washington
      • Renton, Washington, 미국, 98055
        • Valley Medical Center
      • Yakima, Washington, 미국, 98902
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
    • West Virginia
      • Huntington, West Virginia, 미국, 25701
        • Edwards Comprehensive Cancer Center
      • Morgantown, West Virginia, 미국, 26505
        • Monongalia Hospital
    • Wisconsin
      • Eau Claire, Wisconsin, 미국, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Marshfield, Wisconsin, 미국, 54449
        • Marshfield Medical Center-Marshfield
      • Milwaukee, Wisconsin, 미국, 53215
        • Aurora Saint Luke's Medical Center
      • Minocqua, Wisconsin, 미국, 54548
        • Marshfield Medical Center - Minocqua
      • Rice Lake, Wisconsin, 미국, 54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point, Wisconsin, 미국, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Weston, Wisconsin, 미국, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, 미국, 54494
        • Marshfield Clinic - Wisconsin Rapids Center
      • San Juan, 푸에르토 리코, 00917
        • San Juan Community Oncology Group
      • San Juan, 푸에르토 리코, 00927
        • Centro Comprensivo de Cancer de UPR
      • San Juan, 푸에르토 리코, 00936
        • San Juan City Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

13년 이상 (어린이, 성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

비확률 샘플

연구 인구

Patients undergoing treatment for cancer types with commercially available therapies.

설명

Inclusion Criteria:

  • Is consistent with OR has been diagnosed with one of the following:

    • Colorectal cancer: stage IV

    • Non-small cell or small cell lung cancer: stage III/IV

    • Prostate cancer: metastatic prostate cancer

    • Gastric cancer, not otherwise specified (NOS): stage IV

    • Esophageal cancer, NOS: stage IV

    • Adenocarcinoma of gastroesophageal junction: stage IV

    • High grade serous ovarian cancer: stage III/IV

    • Invasive breast carcinoma: stage III/IV

    • Melanoma: stage III/IV

    • Acute myeloid leukemia

    • Multiple myeloma

      • For the purposes of this study,

        • Re-staging is allowed
        • Having more than one primary cancer is allowed, if the patient is being treated solely for one of the eligible cancers listed above
  • Patient should fit in one of the following four clinical scenarios (a-d)

    • Undergoing diagnostic workup for one of the diseases listed for which treatment will likely include a new regimen of standard of care therapy OR
    • Scheduled to begin treatment with a new regimen of standard of care therapy OR
    • Currently progressing on a regimen of standard of care therapy OR
    • Currently being treated with a regimen standard of care therapy, without evidence of progression
  • Requirements for fresh tissue biospecimen collections at enrollment:

    • For clinical scenarios a, b, and c above, freshly collected tumor tissue or bone marrow (BM) aspirate must be submitted at enrollment

      • For clinical scenarios a and b, the fresh tissue collection must be prior to starting therapy

      • For clinical scenario a, the biospecimen collection must be part of a standard of care medical procedure

      • For clinical scenarios b or c, the biospecimen collection may be part of a standard of care medical procedure OR

      • The biospecimen collection may be part of a study-specific procedure ("research only biopsy"), when the patient has a tumor amenable to image guided or direct vision biopsy and is willing and able to undergo a tumor biopsy for molecular profiling

        • Note: For research-only biopsies, the biopsy must not be associated with a significant risk of severe or major complications or death; the procedure cannot be a mediastinal, laparoscopic, open or endoscopic biopsy; nor can the procedure be a brain biopsy; nor can the patient be under the age of majority as determined by each U.S. state
  • Requirements for archival tissue:

    • For clinical scenarios a and b above, archival tissue as outlined below must be submitted IF AVAILABLE

    • For clinical scenarios c and d above, archival tissue as outlined below is REQUIRED

    • Pre-existing archival material (formalin-fixed, paraffin-embedded [FFPE] block, BM aspirate, or unstained slides) that:

      • Contains the cancer type for which the participant is enrolled, and
      • Was collected no more than 5 years prior to initiation of therapy, and
      • Contains at least a surface area of 5 mm^2 and optimal surface area of 25 mm^2 or 3-5 mL cryopreserved bone marrow aspirate to yield 200 million bone marrow mononuclear cells, and
      • Contains at least 10% tumor content. 70% tumor content is optimal, and
      • No more than 1 line of standard of care systemic therapy was administered from the date of archival material collection to the date of initiation of therapy
  • Requirements for blood collection: ALL scenarios require fresh blood collection at enrollment

    • Blood collection for clinical scenarios a, b, and c must take place within 1 week of fresh tumor specimen collection
    • Blood collection for clinical scenario d must take place within 4 weeks of enrollment, and while patient is on treatment
  • Age 13 or older

  • Any sex

  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2

  • Ability to understand and willingness to sign an informed consent document. Consent may be provided by a Legally Authorized Representative (LAR) in accordance with 45 CFR 46.102(i)

  • NCI PDMR INCLUSION CRITERIA: Patients with CRC with mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) status

  • NCI PDMR INCLUSION CRITERIA: Patients with CRC who are 40 years old or younger at time of collection irrespective of mismatch repair deficient (dMMR) or microsatellite instability-high (MSI-H) status

  • NCI PDMR INCLUSION CRITERIA: Patients with BRCA that are either

    • Any race/ethnicity with hormone receptor positive (ER+PR+, ER+PR-, or ER-PR+)
    • African American with triple negative (ER-PR-HER2-)
  • NCI PDMR INCLUSION CRITERIA: Patients with lung cancer (LCA), prostate cancer (PCA), gastroesophageal cancer (GEC), ovarian cancer (OV), acute myeloid leukemia (AML), multiple myeloma (MML)

Exclusion Criteria:

  • Treated with or has already begun treatment with a non-standard of care therapeutic agent (investigational) in an interventional clinical trial

    • For the purposes of this study, past enrollment in clinical trials whereby the patient was randomized and treated with standard-of-care anti-cancer treatment (chemotherapy regimen, surgery and radiation therapy) is allowed
  • Uncontrolled intercurrent illness that in the physician's assessment would pose undue risk for biopsy

  • Use of full dose coumarin-derivative anticoagulants such as warfarin are prohibited. Patients may be switched to low molecular weight (LMW) heparin at physician discretion

    • Low molecular weight (LMW) heparin is permitted for prophylactic or therapeutic use

    • Factor X inhibitors are permitted

    • Use of anti-platelet drugs are permitted

      • Stopping the anticoagulation treatment for biopsy, bone marrow aspirate, or resection should be per site standard operating procedure (SOP)
  • NCI PDMR EXCLUSION CRITERIA: Patients with complete response

  • NCI PDMR EXCLUSION CRITERIA: Patients with invasive fungal infections

  • NCI PDMR EXCLUSION CRITERIA: Patients with active and/or uncontrolled infections or who are still recovering from an infection

    • Actively febrile patients with uncertain etiology of febrile episode
    • All antibiotics for non-prophylactic treatment of infection should be completed at least 1 week (7 days) prior to collection
    • No recurrence of fever or other symptoms related to infection for at least 1 week (7 days) following completion of antibiotics
  • NCI PDMR EXCLUSION CRITERIA: Patients with human immunodeficiency virus (HIV), active or chronic hepatitis (i.e. quantifiable hepatitis B virus [HBV]-deoxyribonucleic acid [DNA] and/or positive hepatitis B surface antigen [HbsAg], quantifiable hepatitis C virus [HCV]-ribonucleic acid [RNA]) or known history of HBV/HCV without documented resolution

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
개입 / 치료
Observational (biospecimen collection, chart review)

Patients undergo collection of tissue samples during baseline and at time of disease progression and collection of blood samples throughout the study, including at time of disease progression. Patients with hematological malignancies also undergo collection of bone marrow and cerebral spinal fluid at the same time points. Archival blood and tissue, as well as bone marrow of patients with hematological malignancies, is also collected if available. Additionally, patients may undergo CT, PET/CT and/or MRI throughout the study, and may undergo paracentesis on study. Patient medical records are reviewed, and data is collected for at least 5 years.

Undergo CT

다른 이름들:
  • CT
  • 고양이
  • 고양이 스캔
  • 컴퓨터 축 단층 촬영
  • 전산화 단층 촬영
  • CT 스캔
  • 단층 촬영
  • 컴퓨터 축 단층 촬영(시술)
  • 컴퓨터 단층촬영(CT) 스캔
  • 진단 CAT 스캔
  • 진단 CAT 스캔 서비스 유형

Undergo MRI

다른 이름들:
  • MRI
  • 자기 공명
  • 자기공명영상 스캔
  • 의료영상, 자기공명 / 핵자기공명
  • 씨
  • MR 이미징
  • MRI 검사
  • NMR 이미징
  • NMRI
  • 핵자기공명영상
  • 자기공명영상(MRI)
  • SMRI
  • 자기공명영상(시술)
  • 구조적 MRI

Undergo PET/CT

다른 이름들:
  • 의료 영상, 양전자 방출 단층 촬영
  • 애완 동물
  • PET 스캔
  • 양전자 방출 단층 촬영 스캔
  • 양전자 방출 단층 촬영
  • PT
  • 양전자방출단층촬영(시술)

Undergo collection of blood, tissue, bone marrow, and cerebral spinal fluid samples

다른 이름들:
  • 생물학적 샘플 수집
  • 생체 표본 수집
  • 표본 수집
  • 샘플 수집

Medical charts are reviewed and data is collected

다른 이름들:
  • 차트 검토

Undergo paracentesis

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Procure, store and distribute longitudinal biospecimens and associated clinical data
기간: Up to 10 years

Will procure, store and distribute longitudinal biospecimens and associated clinical data for current and future cancer research in order to elucidate molecular mechanisms of sensitivity and intrinsic or acquired resistance to standard of care systemic therapies, including immunotherapy. Cases will be grouped according to patient demographics, cancer type and treatment regimen. Statistical analysis will be descriptive and will be analyzed for each Biospecimen Source Site (BSS) as well as study aggregate.

Up to 10 years
Percentage of enrolled patients by cancer type and treatment regimen overall
기간: Until completion of biospecimen collection, up to 3 years

Will assess the percentage of enrolled patients by cancer type and treatment regimen overall and those who contribute samples to the Drug Resistance and Sensitivity Network and other approved investigators. Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.

Until completion of biospecimen collection, up to 3 years
Percentage of minority and underserved study participants accrued
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.

Until completion of biospecimen collection, up to 3 years

2차 결과 측정

결과 측정
측정값 설명
기간
Percentage of minority and underserved study participants accrued
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.

Until completion of biospecimen collection, up to 3 years
Pan-cancer gene panel tumor next generation sequencing test
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.

Until completion of biospecimen collection, up to 3 years
Cancer Research Data Commons, The Cancer Imaging Archive and database of Genotypes and Phenotypes data contribution
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate.

Until completion of biospecimen collection, up to 3 years
Percentage of enrolled patients for whom molecular profiling is attempted
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.

Until completion of biospecimen collection, up to 3 years
Percentage of enrolled patients for whom molecular profiling results are generated
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.

Until completion of biospecimen collection, up to 3 years
Percentage of enrolled patients for whom samples are obtained at each longitudinal timepoint
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.

Until completion of biospecimen collection, up to 3 years
Percentage of collected biospecimens that are delivered to the Patient Derived Models Repository
기간: Until completion of biospecimen collection, up to 3 years

Statistical analysis will be descriptive and will be analyzed for each BSS as well as study aggregate. Will also be assessed by patient demographics, cancer type and treatment regimen.

Until completion of biospecimen collection, up to 3 years

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Lyndsay N Harris, National Cancer Institute (NCI)

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2020년 11월 11일

기본 완료 (추정된)

2027년 4월 30일

연구 완료 (추정된)

2027년 4월 30일

연구 등록 날짜

최초 제출

2020년 3월 18일

QC 기준을 충족하는 최초 제출

2020년 3월 18일

처음 게시됨 (실제)

2020년 3월 19일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 12일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 11일

마지막으로 확인됨

2026년 10월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • NCI-2020-00750
  • NCI-2020-00750 (레지스트리 식별자: CTRP (Clinical Trial Reporting Program))
  • 10323 (기타 식별자: CTEP)
  • 10323 (기타 식별자: Division of Cancer Treatment and Diagnosis)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다